Pretransplant assessment of cyclosporine level as a predictor of cyclosporine dose requirements after kidney transplantation

Introduction and aims Pretransplant administration of cyclosporine (CsA) may reduce post-transplant maintenance dose and consequently CsA inhibitor nephrotoxicity and helps in achieving the desired target C2 levels earlier. The optimum dose or timing of administration of CsA induction dose is still...

Full description

Bibliographic Details
Main Authors: Sahier O El-Khashab, Amin R Soliman, Rabab M Ahmed, Samar Amin
Format: Article
Language:English
Published: SpringerOpen 2019-01-01
Series:The Egyptian Journal of Internal Medicine
Subjects:
Online Access:http://www.esim.eg.net/article.asp?issn=1110-7782;year=2019;volume=31;issue=2;spage=178;epage=184;aulast=El-Khashab
_version_ 1818115958083944448
author Sahier O El-Khashab
Amin R Soliman
Rabab M Ahmed
Samar Amin
author_facet Sahier O El-Khashab
Amin R Soliman
Rabab M Ahmed
Samar Amin
author_sort Sahier O El-Khashab
collection DOAJ
description Introduction and aims Pretransplant administration of cyclosporine (CsA) may reduce post-transplant maintenance dose and consequently CsA inhibitor nephrotoxicity and helps in achieving the desired target C2 levels earlier. The optimum dose or timing of administration of CsA induction dose is still debatable. Patients and methods We compared three different protocols for pretransplant administration of CsA aiming to reach a target C2 therapeutic level of greater than 800 ng/ml on the third day post-transplant. Sixty kidney transplant recipients from Cairo University hospitals were divided into: group 1 (n=20) who received a single CsA induction dose of 2 mg/kg 12 h pretransplant; group 2 (n=20) who received four CsA consecutive doses of 4 mg/kg 48 h pre-transplant; and group 3 (n=20) who received four CsA consecutive doses of 2 mg/kg 48 h pretransplant. Results The desired therapeutic level in the earlier post-transplantation period was achieved in 65% in group 1, 100% in groups 2 and 3). In group 2 a lower dose was needed to maintain C2 within the therapeutic range during the first year post-transplantation (P<0.01). Furthermore, a lower number of cases were complicated by CsA nephrotoxicity in group 2 in comparison to groups 1 and 3 (25, 0, 5% in group 1, 2, 3, respectively, P<0.039). A higher longer dose of CsA pretransplant associated with early withdrawal of CsA had a better effect on graft function than lower or shorter induction doses with late withdrawal as evidenced by lower serum creatinine levels all through the follow-up period in group 2 compared with group 3. Conclusion Forty-eight-hour pretransplant induction with CsA at a dose of 4 mg/kg with early dose reduction post-transplant was associated with lower CsA maintenance and a better 1-year graft function.
first_indexed 2024-12-11T04:14:53Z
format Article
id doaj.art-d252dae67c214d23a00bde573298c035
institution Directory Open Access Journal
issn 1110-7782
2090-9098
language English
last_indexed 2024-12-11T04:14:53Z
publishDate 2019-01-01
publisher SpringerOpen
record_format Article
series The Egyptian Journal of Internal Medicine
spelling doaj.art-d252dae67c214d23a00bde573298c0352022-12-22T01:21:16ZengSpringerOpenThe Egyptian Journal of Internal Medicine1110-77822090-90982019-01-0131217818410.4103/ejim.ejim_79_18Pretransplant assessment of cyclosporine level as a predictor of cyclosporine dose requirements after kidney transplantationSahier O El-KhashabAmin R SolimanRabab M AhmedSamar AminIntroduction and aims Pretransplant administration of cyclosporine (CsA) may reduce post-transplant maintenance dose and consequently CsA inhibitor nephrotoxicity and helps in achieving the desired target C2 levels earlier. The optimum dose or timing of administration of CsA induction dose is still debatable. Patients and methods We compared three different protocols for pretransplant administration of CsA aiming to reach a target C2 therapeutic level of greater than 800 ng/ml on the third day post-transplant. Sixty kidney transplant recipients from Cairo University hospitals were divided into: group 1 (n=20) who received a single CsA induction dose of 2 mg/kg 12 h pretransplant; group 2 (n=20) who received four CsA consecutive doses of 4 mg/kg 48 h pre-transplant; and group 3 (n=20) who received four CsA consecutive doses of 2 mg/kg 48 h pretransplant. Results The desired therapeutic level in the earlier post-transplantation period was achieved in 65% in group 1, 100% in groups 2 and 3). In group 2 a lower dose was needed to maintain C2 within the therapeutic range during the first year post-transplantation (P<0.01). Furthermore, a lower number of cases were complicated by CsA nephrotoxicity in group 2 in comparison to groups 1 and 3 (25, 0, 5% in group 1, 2, 3, respectively, P<0.039). A higher longer dose of CsA pretransplant associated with early withdrawal of CsA had a better effect on graft function than lower or shorter induction doses with late withdrawal as evidenced by lower serum creatinine levels all through the follow-up period in group 2 compared with group 3. Conclusion Forty-eight-hour pretransplant induction with CsA at a dose of 4 mg/kg with early dose reduction post-transplant was associated with lower CsA maintenance and a better 1-year graft function.http://www.esim.eg.net/article.asp?issn=1110-7782;year=2019;volume=31;issue=2;spage=178;epage=184;aulast=El-Khashabcyclosporineearlygraft functionrenal transplantation
spellingShingle Sahier O El-Khashab
Amin R Soliman
Rabab M Ahmed
Samar Amin
Pretransplant assessment of cyclosporine level as a predictor of cyclosporine dose requirements after kidney transplantation
The Egyptian Journal of Internal Medicine
cyclosporine
early
graft function
renal transplantation
title Pretransplant assessment of cyclosporine level as a predictor of cyclosporine dose requirements after kidney transplantation
title_full Pretransplant assessment of cyclosporine level as a predictor of cyclosporine dose requirements after kidney transplantation
title_fullStr Pretransplant assessment of cyclosporine level as a predictor of cyclosporine dose requirements after kidney transplantation
title_full_unstemmed Pretransplant assessment of cyclosporine level as a predictor of cyclosporine dose requirements after kidney transplantation
title_short Pretransplant assessment of cyclosporine level as a predictor of cyclosporine dose requirements after kidney transplantation
title_sort pretransplant assessment of cyclosporine level as a predictor of cyclosporine dose requirements after kidney transplantation
topic cyclosporine
early
graft function
renal transplantation
url http://www.esim.eg.net/article.asp?issn=1110-7782;year=2019;volume=31;issue=2;spage=178;epage=184;aulast=El-Khashab
work_keys_str_mv AT sahieroelkhashab pretransplantassessmentofcyclosporinelevelasapredictorofcyclosporinedoserequirementsafterkidneytransplantation
AT aminrsoliman pretransplantassessmentofcyclosporinelevelasapredictorofcyclosporinedoserequirementsafterkidneytransplantation
AT rababmahmed pretransplantassessmentofcyclosporinelevelasapredictorofcyclosporinedoserequirementsafterkidneytransplantation
AT samaramin pretransplantassessmentofcyclosporinelevelasapredictorofcyclosporinedoserequirementsafterkidneytransplantation